PlainPill

Oxiracetam

The short answer. More people than not who report on Oxiracetam say it helped (66% of 218). It is most often used for focus: 90% of 148 reports say that improved. It is well studied — 5 meta-analyses on PubMed. The most common complaint is irritability.

What users report
66%helped218 reports · high confidence
144 helped30 mixed45 didn't help

From 495 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
5
meta-analyses
19
RCTs
215
papers

What Oxiracetam does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 5 meta-analyses on PubMed ↗ · 19 randomized trials ↗

Psychopharmacology (Berl) · 2018 · Meta-analysis / systematic review
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis

Conclusion: The most effective intervention for dementia available is symptomatic treatment for vascular dementia. Antipsychotic treatment for dementia alleviates cognitive dysfunction less effectively than does symptomatic treatment. Alternative therapies are also effective at present. Further research on causes and very early diagnosis of Alzheimer disease is warranted.

PubMed 29502274 ↗
Front Pharmacol · 2023 · Meta-analysis / systematic review
The efficacy and safety of post-stroke cognitive impairment therapies: an umbrella review

Conclusion: Conclusion: Our study demonstrated that ACEI inhibitors (Donepezil) and NMDA antagonists (Memantine), EGB761, and acupuncture are the ADL and BI, MoCA, and neurological function deficit medication/therapy, respectively, for patients with PSCI. Clinical Trial Registration: https://inplasy.com/inplasy-2022-11-0139/; Identifier: INPLASY2022110139.

PubMed 37693907 ↗
Registered clinical trials

2 human trials on ClinicalTrials.gov test Oxiracetam — 1 completed. See all on ClinicalTrials.gov ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

1500-2250 mgdaily
750 mgdaily
750mgdaily
750 mg2x daily
400-1200 mgdaily
750 mg5x/week

Reported side effects

How often each side effect came up across all reports.

irritability ×5insomnia ×3headache ×2hypomania ×2anxiety ×2tolerance ×2vivid dreams ×1energy ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“Oxi gave me a significant increase in focus, to the point where I could work for 2-3 hours without even checking facebook. / It also helped me with memory (was clearly retaining more info in both short-term and long-term).”
HelpedRead the discussion ↗
“I took 2-3 750 mg of Oxiracetam a day...Similarly, I felt nothing.”
Didn't helpRead the discussion ↗
“Since I've been on this stack and changed my mindset and outlook in my life, everything has improved significantly.”
HelpedRead the discussion ↗
“When dosed I feel stimulated and logical. It was great when taken during my statistics class. I actually made less simple calculation errors during math tests.”
HelpedRead the discussion ↗
Read more Oxiracetam reviews →
Top discussions (5)

Oxiracetam compared

Other options for focus

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate